Holen Sie sich die Stockscreener-App
1.38
4.55%
0.06
Vorhandelsmarkt:
1.41
0.03
+2.17%
Schlusskurs vom Vortag:
$1.32
Offen:
$1.37
24-Stunden-Volumen:
166.53K
Relative Volume:
0.29
Marktkapitalisierung:
$1.10M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-20.26M
KGV:
-0.1616
EPS:
-8.54
Netto-Cashflow:
$-8.25M
1W Leistung:
+2.99%
1M Leistung:
-62.19%
6M Leistung:
-83.82%
1J Leistung:
-95.58%
1-Tages-Spanne:
$1.3105
$1.40
1-Wochen-Bereich:
$1.30
$1.45
52-Wochen-Spanne:
$1.30
$75.60
Oragenics Inc Stock (OGEN) Company Profile
Firmenname
Oragenics Inc
Sektor
Branche
Telefon
813-286-7900
Adresse
4902 Eisenhower Boulevard, Suite 125, Tampa, FL
Vergleichen Sie OGEN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OGEN
Oragenics Inc
|
1.38 | 1.10M | 0 | -20.26M | -8.25M | -8.54 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Oragenics Inc Aktie (OGEN) Neueste Nachrichten
Oragenics Inc. Stock Analysis and ForecastRapid growth trajectories - jammulinksnews.com
Is Oragenics Inc. a good long term investmentPhenomenal returns - jammulinksnews.com
What drives Oragenics Inc. stock pricePhenomenal investment performance - jammulinksnews.com
What analysts say about Oragenics Inc. stockOutstanding yields - jammulinksnews.com
Why Oragenics Inc. stock attracts strong analyst attention5x Profit Potential - Newser
Oragenics Announces Approval of Common Stock Listing on NYSE MKT - AOL.com
Oragenics Partners With Sterling For U.S.-Based Manufacturing Of Concussion Drug ONP-002 - Nasdaq
Oragenics Inc. Secures U.S. Manufacturing Partner for Concussion Drug Ahead of Phase IIb Trials - citybuzz -
Oragenics, Inc. Announces U.S.-Based Drug Manufacturing Agreement to Support ONP-002 Clinical Development - The Manila Times
Oragenics partners with Sterling for concussion drug production By Investing.com - Investing.com South Africa
Oragenics partners with Sterling for concussion drug production - Investing.com
What makes Oragenics Inc. stock price move sharplyHigh Probability Setups - Newser
How Oragenics Inc. stock performs during market volatilityFree Real-Time Market Predictions - Newser
Best Momentum Stock to Buy for July 7th - The Globe and Mail
Oragenics Soars 11.11% on $20M Capital Raise for Clinical Trials - AInvest
Oragenics Closes $16.5 Million Offering of Preferred Stock, Warrants - MarketScreener
Oragenics Raises $16.5M Through Public Offering - TipRanks
Oragenics, Inc. Successfully Closes $16.5 Million Public Offering of Series H Convertible Preferred Stock and Warrants - Nasdaq
Oragenics' Stock Takes A Hit With New Offering Announcement - Finimize
Form 424B5 ORAGENICS INC - StreetInsider
Oragenics shares plunge following announcement of $20 million preferred stock sale - MSN
Oragenics Inc. Announces $20 Million Preferred Stock and Warrant Offering to Fund Concussion Trials and R&D - citybuzz -
Oragenics stock tumbles after announcing $20 million preferred stock offering - Investing.com
Why Is Oragenics Stock (OGEN) Down 55% Today? - TipRanks
Oragenics announces $20 million preferred stock offering - Investing.com Australia
Oragenics, Inc. Announces $20 Million Public Offering of Series H Convertible Preferred Stock and Warrants - Nasdaq
Oragenics announces $20 million preferred stock offering By Investing.com - Investing.com UK
Oragenics, Inc. Announces Pricing of Public Offering of up to $20 Million of Preferred Stock and Warrants - TradingView
Major Shareholder Odyssey Health Sells Oragenics Stock! - TipRanks
Future of Oral Probiotic Supplements | Innovations in Oral - openPR.com
Oragenics Inc. to Showcase Concussion Treatment Candidate at Major 2025 Conferences - citybuzz -
Oragenics to Present at 2025 BIO International Convention and At - GuruFocus
Oragenics, Inc. to Present ONP-002 at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium - Nasdaq
GlobeNewswire by Notified - The Manila Times
Oragenics to Present at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium | OGEN Stock News - GuruFocus
Oragenics to Present at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium - The Manila Times
Pre-market Movers: EVGN, WINT, CARM, UNCY... - RTTNews
Oragenics to Present at 2025 BIO International Convention - GlobeNewswire
Top stock gains: US stocks posting the highest gains today - Yahoo
Rocket Lab Corporation (RKLB): A Bull Case Theory - Yahoo
Upstart Holdings, Inc. (UPST): A Bull Case Theory - Yahoo
Finanzdaten der Oragenics Inc-Aktie (OGEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):